tirzepatide off the market Eli Lilly's is FDA's drug shortage list: Here's what it means The Impact of New FDA

Keep them in their original packaging to protect them from light

Zepbound is a dual-action (GLP-1/GIP) weekly injectable that is also FDA-approved for weight loss

Brain Health and Neurological Benefits Exciting research shows that GLP-1 medications may have impressive effects on brain health: They reduce the risk of Alzheimers disease and dementia They help protect against Parkinsons disease They lower the risk of seizures They may reduce stroke risk and improve recovery after stroke They show benefits for Huntingtons disease in early studies A January 2025 study from Washington University found that people taking GLP-1 medications had a decreased risk of neurocognitive disorders like Alzheimers

Large clinical trials including LEADER, SUSTAIN-6, and EXSCEL have not identified increased fracture rates with GLP-1 therapy compared to placebo

For some people, however, the side effects are reason enough to discontinue use of the medications

These projections assume no significant delays occur during the regulatory review process